DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 5.31% to $14.28 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.24% to 20,173.89 and the Dow Jones Industrial Average falling 0.25% to 43,717.48.
Corbus Pharmaceuticals Holdings Inc. closed $47.62 below its 52-week high ($61.90), which the company achieved on July 31st.
The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 0.43% to $4.63, Fortress Biotech Inc. (FBIO) fell 4.64% to $1.85, and Viking Therapeutics Inc. $(VKTX)$ rose 0.43% to $47.23.
Trading volume (348,760) eclipsed its 50-day average volume of 340,780.
Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 16, 2024 17:22 ET (22:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments